Wird geladen...
Tricalcium phosphate and hydroxyapatite treatment for benign cavitary bone lesions: A prospective clinical trial
Benign bone tumors are surgically treated by curettage and by filling the defect using bone grafts or bone substitutes, such as hydroxyapatite crystals and tricalcium phosphate. The tricalcium phosphate mixed with hydroxyapatite, although fragile, is a good alternative with good integration. Fifteen...
Gespeichert in:
| Veröffentlicht in: | Exp Ther Med |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604753/ https://ncbi.nlm.nih.gov/pubmed/33149779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9345 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|